ELIXFElixxer Ltd.

About Elixxer Ltd. (ELIXF)

Elixxer Ltd. (ELIXF) is a Drug Manufacturers - Specialty & Generic company headquartered in Montreal, QC, Canada whose shares trade over-the-counter on the Pink tier.

ELXR Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: ELXR). Through its partners ELXR presently will has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.

Products and services

Elixxer invests in the legal global cannabis market. The Company’s aim is to be involved and invested in jurisdictions globally that allow legal cultivation and production of cannabis products, with the exception of investments in businesses operating in the United States. To date, the Company has expanded to securing significant positions in emerging legal cannabis companies in Australia, Canada, Jamaica, Switzerland and Italy.

ELIXF key facts

Ticker symbol

ELIXF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Montreal, QC, Canada

Country of incorporation

CA

Year of incorporation

2004

Employees

7

Estimated market cap

$69.2K (as of May 9, 2025)

Shares outstanding

11,338,887

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Interim Financial Report (Sep 30, 2022)

Elixxer Ltd. leadership

• Ferras Zalt — CEO
• Kym No — Acting CFO
• Michael Kozub — Corporate Secretary

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with E